Kristen Starbuck

480 total citations
29 papers, 314 citations indexed

About

Kristen Starbuck is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Kristen Starbuck has authored 29 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Obstetrics and Gynecology and 9 papers in Reproductive Medicine. Recurrent topics in Kristen Starbuck's work include Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer, Lipids, and Metabolism (3 papers). Kristen Starbuck is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer, Lipids, and Metabolism (3 papers). Kristen Starbuck collaborates with scholars based in United States and Türkiye. Kristen Starbuck's co-authors include Emese Zsíros, Paul Mayor, Peter G. Rose, Richard D. Drake, Kunle Odunsi, G. Thomas Budd, Kevin H. Eng, Kayla Morrell, J. Brian Szender and Kirsten B. Moysich and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Kristen Starbuck

26 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristen Starbuck United States 10 105 84 77 56 53 29 314
Kayla Morrell United States 8 121 1.2× 64 0.8× 75 1.0× 69 1.2× 56 1.1× 17 333
C. Roemer-Bécuwe France 8 37 0.4× 152 1.8× 15 0.2× 105 1.9× 33 0.6× 15 346
Alan Gillespie United Kingdom 12 74 0.7× 21 0.3× 389 5.1× 60 1.1× 26 0.5× 18 556
Joseph J. Noh South Korea 11 115 1.1× 48 0.6× 13 0.2× 29 0.5× 8 0.2× 56 300
Wen-Ling Lee Taiwan 14 131 1.2× 23 0.3× 42 0.5× 99 1.8× 10 0.2× 21 489
Jason Tan Australia 11 70 0.7× 34 0.4× 57 0.7× 51 0.9× 2 0.0× 22 287
Shiho Kuji Japan 10 117 1.1× 185 2.2× 32 0.4× 95 1.7× 2 0.0× 24 431
Demetrios Minaretzis Greece 10 91 0.9× 80 1.0× 220 2.9× 31 0.6× 10 0.2× 15 489
Archana Rao Australia 9 141 1.3× 63 0.8× 8 0.1× 21 0.4× 6 0.1× 25 269
Kristin J. Moore United States 7 75 0.7× 115 1.4× 23 0.3× 46 0.8× 5 0.1× 32 249

Countries citing papers authored by Kristen Starbuck

Since Specialization
Citations

This map shows the geographic impact of Kristen Starbuck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristen Starbuck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristen Starbuck more than expected).

Fields of papers citing papers by Kristen Starbuck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristen Starbuck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristen Starbuck. The network helps show where Kristen Starbuck may publish in the future.

Co-authorship network of co-authors of Kristen Starbuck

This figure shows the co-authorship network connecting the top 25 collaborators of Kristen Starbuck. A scholar is included among the top collaborators of Kristen Starbuck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristen Starbuck. Kristen Starbuck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Remick, Jill, et al.. (2024). Induction chemotherapy with cemiplimab in a patient with coexistent vulvar cancer and autoimmune disease: A case report. Gynecologic Oncology Reports. 55. 101487–101487. 1 indexed citations
2.
McCall, Neal S., Tony Y. Eng, Joseph W. Shelton, et al.. (2022). Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapy. Gynecologic Oncology Reports. 44. 101086–101086. 2 indexed citations
3.
Moysich, Kirsten B., et al.. (2020). Clinical needs for transgender men in the gynecologic oncology setting. Gynecologic Oncology. 159(3). 899–905. 23 indexed citations
4.
Lynam, Sarah, Kayla Morrell, Kevin H. Eng, et al.. (2019). Implementation of a restrictive blood transfusion protocol in a gynecologic oncology service. PubMed. 1(3). 1–5. 4 indexed citations
5.
Lynam, Sarah, Paul Mayor, Kevin H. Eng, et al.. (2019). Breaking the silence: Burnout among gynecologic oncology trainees is an impending crisis. Gynecologic Oncology. 154. 9–10. 1 indexed citations
6.
Starbuck, Kristen, Kayla Morrell, Kunle Odunsi, et al.. (2018). TIGIT ligands CD155, CD112, and galectin-9 are associated with immune infiltration and increased overall survival in ovarian cancer. Gynecologic Oncology. 149. 56–56. 1 indexed citations
7.
Starbuck, Kristen, J. Brian Szender, William D. Duncan, et al.. (2018). Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer. PLoS ONE. 13(11). e0206913–e0206913. 9 indexed citations
8.
Minlikeeva, Albina N., Kirsten B. Moysich, Paul Mayor, et al.. (2018). Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes & Control. 29(2). 201–212. 4 indexed citations
9.
Morrell, Kayla, Kevin H. Eng, Alan D. Hutson, et al.. (2018). Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery. JAMA Network Open. 1(8). e185452–e185452. 88 indexed citations
10.
Starbuck, Kristen, Kevin H. Eng, Kayla Morrell, et al.. (2018). Prognostic impact of adjuvant chemotherapy treatment delays for ovarian cancer: A cohort study. Gynecologic Oncology. 149. 127–128.
11.
Mayor, Paul, Kristen Starbuck, & Emese Zsíros. (2018). Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecologic Oncology. 150(2). 361–369. 26 indexed citations
12.
Eng, Kevin H., Kayla Morrell, Kristen Starbuck, et al.. (2017). Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer. Gynecologic Oncology. 146(1). 52–57. 14 indexed citations
13.
Starbuck, Kristen, et al.. (2017). Abstract 956: Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model. Cancer Research. 77(13_Supplement). 956–956. 3 indexed citations
14.
Starbuck, Kristen, Richard D. Drake, G. Thomas Budd, & Peter G. Rose. (2016). Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature. Anticancer Research. 36(11). 6161–6164. 36 indexed citations
15.
Rauh‐Hain, J. Alejandro, Kristen Starbuck, Larissa A. Meyer, et al.. (2015). Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: A National Cancer Database analysis. Gynecologic Oncology. 139(1). 84–89. 28 indexed citations
16.
Starbuck, Kristen, et al.. (2015). Eradicating ovarian cancer stem cells by targeting the tumor-associated carbohydrate antigen sialyl Tn. Gynecologic Oncology. 139(3). 590–590. 1 indexed citations
17.
Starbuck, Kristen, J. Alejandro Rauh‐Hain, Joel Clemmer, John O. Schorge, & Marcela G. del Carmen. (2015). Patterns of Care, Predictors and Outcomes of Chemotherapy for Uterine Carcinosarcoma: A population-based analysis. Gynecologic Oncology. 139(3). 598–598. 2 indexed citations
18.
Wells, Julie, Miguel N. Rivera, Woo‐Jae Kim, Kristen Starbuck, & Daniel A. Haber. (2010). The Predominant WT1 Isoform (+KTS) Encodes a DNA-Binding Protein Targeting the Planar Cell Polarity Gene Scribble in Renal Podocytes. Molecular Cancer Research. 8(7). 975–985. 21 indexed citations
19.
20.
Starbuck, Kristen, Christine Garcia, Qian Wu, & Carolyn D. Runowicz. (2010). Multimodal therapy in the treatment of vaginal adenocarcinoma arising from endocervicosis. Gynecologic Oncology. 120(1). 158–159. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kayla Morrell Breakdown of academic impact, for papers by C. Roemer-Bécuwe Breakdown of academic impact, for papers by Alan Gillespie Breakdown of academic impact, for papers by Joseph J. Noh Breakdown of academic impact, for papers by Wen-Ling Lee Breakdown of academic impact, for papers by Jason Tan Breakdown of academic impact, for papers by Shiho Kuji Breakdown of academic impact, for papers by Demetrios Minaretzis Breakdown of academic impact, for papers by Archana Rao Breakdown of academic impact, for papers by Kristin J. Moore
Rankless by CCL
2026